Inhibikase Therapeutics Stock Price History

Inhibikase Therapeutics Stock Price History Chart

Inhibikase Therapeutics January 31, 2025 Stock Price Synopsis

Various analyses of Inhibikase Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Inhibikase Stock. It can be used to describe the percentage change in the price of Inhibikase Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Inhibikase Stock. When benchmark price declines in a down market, there may be an uptick in Inhibikase Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Inhibikase Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Inhibikase Stock and then apply it to test your longer-term investment strategies against Inhibikase.

Inhibikase Stock Price History Data

The price series of Inhibikase Therapeutics for the period between Sat, Nov 2, 2024 and Fri, Jan 31, 2025 has a statistical range of 2.05 with a coefficient of variation of 14.78. Under current investment horizon, the daily prices are spread out with arithmetic mean of 2.81. The median price for the last 90 days is 2.8. The company completed 1:6 stock split on 30th of June 2023.

Inhibikase Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Inhibikase is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Inhibikase Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Inhibikase Therapeutics stock prices may prove useful in developing a viable investing in Inhibikase Therapeutics

Inhibikase Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.

Predictive indicators are helping investors to find signals for Inhibikase Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Inhibikase Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Inhibikase to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

When running Inhibikase Therapeutics' price analysis, check to measure Inhibikase Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibikase Therapeutics is operating at the current time. Most of Inhibikase Therapeutics' value examination focuses on studying past and present price action to predict the probability of Inhibikase Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibikase Therapeutics' price. Additionally, you may evaluate how the addition of Inhibikase Therapeutics to your portfolios can decrease your overall portfolio volatility.